City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
ZS and Quartic will collaborate to help drive resilience, increase adoption of Industry 4.0 and improve predictive decision-making across manufacturing
This new fund is amongst the largest for the sector in India
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
The drug will be available in 600 hospitals and 105 DTPs
It is developing the drug candidate to potentially treat immunological diseases
Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes
Subscribe To Our Newsletter & Stay Updated